Market revenue in 2023 | USD 157.6 million |
Market revenue in 2030 | USD 302.0 million |
Growth rate | 9.7% (CAGR from 2023 to 2030) |
Largest segment | Dna chips |
Fastest growing segment | Lab-on-chip |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Tissue Arrays, Cell Arrays, DNA Chips, Lab-on-chip, Protein Chips |
Key market players worldwide | Agilent Technologies Inc, PerkinElmer, Illumina Inc, Bio-Rad Laboratories Inc, Standard BioTools Inc, GE HealthCare Technologies Inc Common Stock, Thermo Fisher Scientific Inc, Qiagen NV, Randox |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biochip market will help companies and investors design strategic landscapes.
Dna chips was the largest segment with a revenue share of 39.02% in 2024. Horizon Databook has segmented the Denmark biochip market based on tissue arrays, cell arrays, dna chips, lab-on-chip, protein chips covering the revenue growth of each sub-segment from 2018 to 2030.
According to the World Population Review, in 2022, Denmark was ranked 5th globally in terms of number of cancer cases. In Denmark, 334.9 people per 100,000 had cancer in 2020. Thus, the high burden of target conditions is fueling the demand for advanced therapeutics and diagnostics.
The country’s market is majorly driven by the significantly growing demand for precision medicine, rising R&D expenditure by biopharmaceutical companies, and the evolving biotechnology sector in the country. For instance, according to the Ministry of Foreign Affairs of Denmark, the country is ranked 3rd in Europe in the biotechnology sector and has the world’s greatest percentage of patents in biotechnology.
Moreover, increasing applications of proteomics in drug discovery and precision diagnostics have compelled companies to invest in proteomics technologies. For instance, in January 2023 Novo Holdings invested USD 40 million in Evosep, a leading proteomics company.
Horizon Databook provides a detailed overview of country-level data and insights on the Denmark biochip market, including forecasts for subscribers. This country databook contains high-level insights into Denmark biochip market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account